CHOC neuro-oncologist initiated a clinical trial to test a vaccine for DIPG, a rare and devastating cancer.
New mental health app supports pediatric cancer survivors
CHOC oncologists developed an app to promote inclusion and support pediatric cancer survivors facing mental health challenges.
Innovative protocol studies treatment for rare pediatric PTCL and NK/T-Cell lymphoma
CHOC helps develop innovative treatment protocols for PTCL and NK/T-cell lymphoma, which are now available for patients.
Virtual psychosocial support improves adolescent and young adult oncology outcomes during pandemic
When the pandemic hit, CHOC’s psychosocial programs for adolescents and young adults with cancer went virtual but brought new opportunities.
CHOC oncologist joins career development program aimed at increasing diversity in clinical trials
With the program’s training, Dr. Sonia Morales will help families fully understand their cancer diagnoses, treatment plan and survivorship roadmap.
CHOC’s After Cancer Treatment Survivorship program recognized with an award for collaboration
The ACTS program at the Hyundai Cancer Institute at CHOC receives recognition for their work to provide long-term care to cancer survivors.
